ES2098263T3 - 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos. - Google Patents

8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.

Info

Publication number
ES2098263T3
ES2098263T3 ES90906872T ES90906872T ES2098263T3 ES 2098263 T3 ES2098263 T3 ES 2098263T3 ES 90906872 T ES90906872 T ES 90906872T ES 90906872 T ES90906872 T ES 90906872T ES 2098263 T3 ES2098263 T3 ES 2098263T3
Authority
ES
Spain
Prior art keywords
alpha
ergolins
acilamino
medicines
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90906872T
Other languages
English (en)
Inventor
Gerhard Sauer
Thomas Brumby
Helmut Wachtel
Jonathan Turner
Peter Andreas Loschmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2098263T3 publication Critical patent/ES2098263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE DESCRIBEN COMPUESTOS DE LA FORMULA (I) EN LOS QUE R (AL CUADRADO) , R ELEVADO 6 Y R ELEVADO 8 TIENEN LOS SIGNIFICADOS DADOS EN LA DESCRIPCION, SU PREPARACION Y SU USO COMO MEDICAMENTOS.
ES90906872T 1989-05-12 1990-05-10 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos. Expired - Lifetime ES2098263T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3915950A DE3915950A1 (de) 1989-05-12 1989-05-12 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES2098263T3 true ES2098263T3 (es) 1997-05-01

Family

ID=6380759

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90906872T Expired - Lifetime ES2098263T3 (es) 1989-05-12 1990-05-10 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.

Country Status (14)

Country Link
US (2) US5212178A (es)
EP (1) EP0427827B1 (es)
JP (1) JPH04500681A (es)
AT (1) ATE147742T1 (es)
CA (1) CA2028832A1 (es)
CZ (2) CZ278981B6 (es)
DD (1) DD294259A5 (es)
DE (2) DE3915950A1 (es)
DK (1) DK0427827T3 (es)
ES (1) ES2098263T3 (es)
HU (1) HU212814B (es)
PT (1) PT94011B (es)
SK (2) SK277997B6 (es)
WO (1) WO1990013550A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018332A (en) * 1997-11-21 2000-01-25 Ark Interface Ii, Inc. Overscan user interface
US8113807B2 (en) * 2007-08-24 2012-02-14 Timothy Wilkinson Methods and apparatus for fabricating structures
SG10201509139QA (en) * 2011-12-19 2015-12-30 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
WO2016118541A1 (en) 2015-01-20 2016-07-28 Xoc Pharmaceuticals, Inc Ergoline compounds and uses thereof
JP2018502889A (ja) * 2015-01-20 2018-02-01 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ イソエルゴリン化合物およびその使用
MX2019014272A (es) 2017-06-01 2020-12-11 Xoc Pharmaceuticals Inc Compuestos policiclicos y usos de los mismos.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
CH654838A5 (fr) * 1980-07-25 1986-03-14 Sandoz Ag Ergolinderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen.
DE3135305C2 (de) * 1981-09-03 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
NL8400333A (nl) * 1983-02-16 1984-09-17 Sandoz Ag Moederkoornalkaloiden, hun bereiding en hun toepassing.
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
ATE107647T1 (de) * 1984-04-09 1994-07-15 Schering Ag 2-substituierte ergolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3544365A1 (de) * 1984-12-24 1986-07-03 Sandoz-Patent-GmbH, 7850 Lörrach 8(alpha)-acylaminoergoline
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
DE3528584A1 (de) * 1985-08-06 1987-02-19 Schering Ag Neue 1-alkyl-ergolin-thioharnstoffderivate
HUT45248A (en) * 1986-01-24 1988-06-28 Sandoz Ag Process for producing 8alpha-(acylamino)-ergoline derivatives and pharmaceuticals comprising such compounds
DE3700825A1 (de) * 1986-01-24 1987-07-30 Sandoz Ag 8(alpha)-acylaminoergoline, ihre herstellung und verwendung
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
DE3708028A1 (de) * 1987-03-10 1988-09-22 Schering Ag Verfahren zur herstellung von 2,3ss-dihydroergolinen, 2-substituierte 2,3ss-dihydroergoline und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
CZ279080B6 (en) 1994-12-15
DE3915950A1 (de) 1990-11-15
DD294259A5 (de) 1991-09-26
SK233190A3 (en) 1995-09-13
PT94011A (pt) 1991-01-08
PT94011B (pt) 1996-12-31
SK277997B6 (en) 1995-09-13
CZ233190A3 (en) 1994-02-16
WO1990013550A1 (de) 1990-11-15
SK260491A3 (en) 1995-09-13
CZ278981B6 (en) 1994-11-16
HUT56363A (en) 1991-08-28
US5212178A (en) 1993-05-18
EP0427827A1 (de) 1991-05-22
CA2028832A1 (en) 1990-11-13
SK277996B6 (en) 1995-09-13
US5547958A (en) 1996-08-20
HU904426D0 (en) 1991-07-29
JPH04500681A (ja) 1992-02-06
DE59010633D1 (de) 1997-03-06
DK0427827T3 (da) 1997-07-07
HU212814B (hu) 1998-08-28
CZ260491A3 (en) 1993-03-17
ATE147742T1 (de) 1997-02-15
EP0427827B1 (de) 1997-01-15

Similar Documents

Publication Publication Date Title
NL300136I2 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
DK0493480T3 (da) Dehydrodidemnin B
IT8847556A0 (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti
FI922798A7 (fi) GABA-B-selektiivisen agonistien käyttö yskänlääkkeinä
AU6311190A (en) Substituted 2-amidotetralins as melatonin agonists and antagonists
NO900279L (no) Alkylerte polyetyleniminderivater og fremgangsmaate for fremstilling derav samt anvendelse av derivatene.
KR880701523A (ko) N,n-디알킬알칸아미드로 되는 조성물 및 그 용도
BR9003915A (pt) Mancal radial com rolamento pre-comprimido
PH16204A (en) 5-(-4-(diarylmethyl)-1-piperazinylalkyl)benzimidazole derivatives,their pharmaceutical compositions and use
IT1219542B (it) Derivati pepticidi,loro preparazione e loro impiego come medicamenti
IT1230703B (it) Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
SE8400445D0 (sv) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use
ATE6358T1 (de) 2-aminotetralin-verbindungen und pharmazeutische zusammensetzungen mit zentraler alpha1-agonist- wirksamkeit.
IT8820388A0 (it) Composizione oftalmologica.
ES2098263T3 (es) 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.
NO890504D0 (no) Vandig, flytende blekepreparat.
FI883370A0 (fi) Vaakasuuntainen, voima-avusteinen nahanlevityspöytä
ES2060944T3 (es) Derivados de 2,5,6,7-tetranor-4,8-inter-m-fenileno de pgi2 (prostaglandina i2).
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
IT1157724B (it) Antracene-9,10-bis-carbonil-idrazoni e loro derivati dotati di attivita' farmacologica e procedure di preparazione
IT8720707A0 (it) Impiego del 2,4-monofurfuriliden-sorbitolo ad uso cosmetico.
SE7713700L (sv) 2-substituerade-1-(omega-aminoalkoxi)bensener
ZA908300B (en) Benzimidazole derivatives,their production and use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 427827

Country of ref document: ES